March 31, 2023 - Sustained Relief from Chronic Pain and more news…

Published: 31 March 2023

March 31, 2023

Focused Ultrasound Offers Sustained Relief From Chronic Neuropathic Pain

A clinical trial using focused ultrasound medial thalamotomy to treat patients with chronic pain showed sustained pain relief over time.
The 55 participants enrolled presented with spinal cord injury, trigeminal neuralgia, post-discectomy radiculopathy, and other types of nerve-related pain.
One year after treatment, half of the participants had stopped taking opioid pain relievers.

Focused Ultrasound–Facilitated Mitochondria Delivery Helps Treat Stroke

A collaborative team used focused ultrasound to open the blood-brain barrier and enhance delivery of mitochondria to the brain cells in a preclinical model of stroke.
The treatment decreased the cerebral infarction volume and increased cell survival and function.

Watch Now: Webinar on the Role of Mentorship for Women Scientists

The Foundation recently hosted a discussion about the importance of mentorship in fostering the next generation of women scientists.
Four leaders in the field of focused ultrasound shared their perspectives on mentorship.

Watch the Recording

‘Why It Takes So Long’ Blog Series: Societies and Guidelines

In this eighth blog in the series, Mark Carol, MD, a senior consultant at the Foundation, addresses the importance of garnering support from professional societies and technology assessment associations.
He explains why additional data may be required before new procedures are incorporated into official clinical guidelines.

Read the Blog

ARPA-H Launches Online Competition to Transform Health

The Advanced Research Projects Agency for Health (ARPA-H) is seeking revolutionary ideas to transform health.
ARPA-H's "Dash to Accelerate Health Outcomes" program is now accepting these revolutionary ideas for a funding competition.
Focused ultrasound researchers and companies are encouraged to apply. The deadline to submit ideas is April 7.

Learn More

Forwarded this email by a friend? Sign up to receive these emails here.

“[Dr. Gallay’s study] might be the longest period of follow up for focused ultrasound treatment of neuropathic pain to date. The sustained pain relief and reduction in opioid use are incredibly impactful findings. ”

‒ Tim Meakem, MD, the Foundation’s chief medical officer

Do you have news for our newsletter? Tell us about it!